Molecular Biology Core
分子生物学核心
基本信息
- 批准号:10618376
- 负责人:
- 金额:$ 22.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-05 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAntibody FormationApplications GrantsArkansasAwardCenters of Research ExcellenceCloningCore FacilityDNADNA Sequencing FacilityDNA biosynthesisDNA sequencingDataDedicationsDoctor of PhilosophyEnsureEquationEquipmentFee-for-Service PlansFeesFlow CytometryFundingGelGenesGenomic LibraryGenomicsGoalsGrowthHuman ResourcesImmunologyInflammatoryInflammatory ResponseInstitutionInvestmentsLaboratory PersonnelMaintenanceManuscriptsMedicalMedicineMethodsMicrobial Genome SequencingMicrobiologyModernizationMolecular BiologyOpportunistic InfectionsPathogenesisPhasePreparationProteinsRNARecoveryResearchResearch InfrastructureResearch PersonnelResourcesSamplingScienceScientistService delivery modelServicesSideSupervisionTechnologyTimeTrainingUniversitiesValidationWestern BlottingWorkbasecellular imagingcollegecostequipment acquisitiongenome-wideinstrumentinstrumentationmicrobialmicroscopic imagingnext generationnext generation sequencingoperationpathogenprogramsprotein expressionprotein purificationquantitative imagingresponsesuccesstooluser-friendlyvoucher
项目摘要
PROJECT SUMMARY/ABSTRACT
In Phases I and II, the Center for Microbial Pathogenesis and Host Inflammatory Responses (CMPHIR)
established and maintained a Research and Technical Advancement Core to fill experimental gaps in the
resources available in institutional cores maintained by the UAMS College of Medicine. One of these was a DNA
Sequencing Core. However, the capability of this core was limited to single-gene sequencing. While this was an
important and necessary service, it was not sufficient, particularly in an era of genomic and next-generation
sequencing technology. Thus, the CMPHIR also invested heavily in augmenting the resources available in the
existing DNA Sequencing Core. We accomplished this task, and, in Phase III, we propose to integrate these
services under the common umbrella of a Molecular Biology Core (Core B) capable of providing CMPHIR and
other UAMS investigators with the resources they need, particularly with respect to the pathogen side of the
host–pathogen equation. The activities of Core B include enhancing the capability of obtaining high-quality RNA,
DNA, and protein samples for analysis; high-throughput single-gene sequencing using conventional Sanger
methods; next-generation sequencing of microbial genomes and genomic libraries; protein expression and
purification; and antibody production. The proposed Core B will be supported through a combination of CMPHIR
funding and continued institutional support. Daily operations will be supervised by Dr. Jon S. Blevins, Director,
who will work with 2 full-time technicians. One of these technicians will have primary responsibility for the DNA
component of Core B, while the other will have primary responsibility for the protein component. To ensure
consistency and promote self-sustainability, Core B instruments will be operated by these technicians on behalf
of CMPHIR and UAMS investigators on a fee-for-service basis. This will allow us to recover a significant
proportion of the costs and thereby ensure the ability to upgrade and maintain the equipment in this core as
needed as we move forward into Phase III and beyond.
项目概要/摘要
在第一阶段和第二阶段,微生物发病机制和宿主炎症反应中心 (CMPHIR)
建立并维持一个研究和技术进步核心,以填补实验空白
UAMS 医学院维护的机构核心中可用的资源之一就是 DNA。
然而,该核心的功能仅限于单基因测序。
重要且必要的服务,但这还不够,特别是在基因组和下一代时代
因此,CMPHIR 还投入了大量资金来增加可用资源。
我们完成了这项任务,并且在第三阶段,我们建议整合这些。
分子生物学核心(核心 B)的共同保护伞下的服务能够提供 CMPHIR 和
其他 UAMS 调查人员拥有他们所需的资源,特别是在病原体方面
Core B 的活性包括增强获得高质量 RNA 的能力,
使用传统 Sanger 进行高通量单基因测序分析;
微生物基因组和基因组蛋白表达的新一代测序;
拟议的核心 B 将通过 CMPHIR 的组合得到支持。
资金和持续的机构支持将由董事 Jon S. Blevins 博士监督。
他将与 2 名全职技术人员一起工作,其中一名技术人员将主要负责 DNA。
核心B的组成部分,而另一个将主要负责蛋白质组成部分以确保。
一致性并促进自我可持续性,Core B仪器将由这些技术人员代表操作
CMPHIR 和 UAMS 调查员按服务收费,这将使我们能够收回大量资金。
成本比例,从而确保该核心设备的升级和维护能力
当我们进入第三阶段及以后阶段时需要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jon Scott Blevins其他文献
Jon Scott Blevins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jon Scott Blevins', 18)}}的其他基金
Cyclic di-AMP-dependent signaling in tickborne relapsing fever Borrelia
蜱传回归热伯氏疏螺旋体中的环状双 AMP 依赖性信号传导
- 批准号:
10503309 - 财政年份:2022
- 资助金额:
$ 22.8万 - 项目类别:
Cyclic di-AMP-dependent signaling in tickborne relapsing fever Borrelia
蜱传回归热伯氏疏螺旋体中的环状双 AMP 依赖性信号传导
- 批准号:
10679004 - 财政年份:2022
- 资助金额:
$ 22.8万 - 项目类别:
Cyclic di-GMP Second Messenger Signaling in the Tickborne Relapsing Fever Spirochete, Borrelia turicatae
蜱传回归热螺旋体、Borrelia turicatae 中的环状 di-GMP 第二信使信号传导
- 批准号:
10378138 - 财政年份:2021
- 资助金额:
$ 22.8万 - 项目类别:
Rrp2-dependent gene regulation in Borrelia burgdorferi
伯氏疏螺旋体中 Rrp2 依赖性基因调控
- 批准号:
9090056 - 财政年份:2015
- 资助金额:
$ 22.8万 - 项目类别:
Rrp2-dependent gene regulation in Borrelia burgdorferi
伯氏疏螺旋体中 Rrp2 依赖性基因调控
- 批准号:
8951367 - 财政年份:2015
- 资助金额:
$ 22.8万 - 项目类别:
RpoS-mediated virulence regulation in Borrelia burgdorferi
RpoS 介导的伯氏疏螺旋体毒力调控
- 批准号:
8722793 - 财政年份:2013
- 资助金额:
$ 22.8万 - 项目类别:
RpoS-mediated virulence regulation in Borrelia burgdorferi
RpoS 介导的伯氏疏螺旋体毒力调控
- 批准号:
8259762 - 财政年份:2010
- 资助金额:
$ 22.8万 - 项目类别:
RpoS-mediated virulence regulation in Borrelia burgdorferi
RpoS 介导的伯氏疏螺旋体毒力调控
- 批准号:
8449257 - 财政年份:2010
- 资助金额:
$ 22.8万 - 项目类别:
RpoS-mediated virulence regulation in Borrelia burgdorferi
RpoS 介导的伯氏疏螺旋体毒力调控
- 批准号:
7992838 - 财政年份:2010
- 资助金额:
$ 22.8万 - 项目类别:
相似国自然基金
Tfh细胞调节自身抗体形成在溃疡性结肠炎体液免疫应答中的作用
- 批准号:81170361
- 批准年份:2011
- 资助金额:50.0 万元
- 项目类别:面上项目
胞内化抗体介导的HBcAg去功能化抑制HBV核壳体形成的机制研究
- 批准号:81070335
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
老年性和致病性II型胶原位点自身抗体形成机理探讨
- 批准号:39870857
- 批准年份:1998
- 资助金额:11.0 万元
- 项目类别:面上项目
相似海外基金
Targeting autoreactive antibodies for the therapy of MOG antibody-associated disease
靶向自身反应性抗体治疗 MOG 抗体相关疾病
- 批准号:
10250601 - 财政年份:2021
- 资助金额:
$ 22.8万 - 项目类别:
Improving long-term allograft survival in kidney transplantation by targeting B cell survival cytokines
通过靶向 B 细胞存活细胞因子提高肾移植中的长期同种异体移植物存活率
- 批准号:
9805838 - 财政年份:2019
- 资助金额:
$ 22.8万 - 项目类别: